S&P 500 – 6,846.61 (+0.21%)

Dow Jones – 47,927.96 (+1.18%)

NASDAQ – 23,468.30 (-0.25%)

• Markets End Higher as Defensive Sectors Lead Gains: U.S. stocks finished higher on Tuesday as strength in the health care, energy, and consumer staples sectors outweighed declines in technology shares.
• Trump Backs Bipartisan Senate Deal to End Record Shutdown: Trump supports a bipartisan Senate plan aimed at ending the record 41-day U.S. government shutdown.
• Trump Floats $2,000 Tariff-Funded Payout Proposal: President Trump has proposed a $2,000 direct payment to Americans funded by tariff revenues.
• Amgen’s Repatha Cuts Heart Attack Risk by 36% in Major Study: Amgen’s cholesterol drug Repatha reduced heart attack risk by 36% in a landmark clinical trial.
• Senate Introduces Landmark Bipartisan Crypto Regulation Bill: The Senate unveiled a bipartisan bill to establish clear regulatory rules for the U.S. cryptocurrency market.
• Risk Appetite Improves as Bonds Sell Off, Dollar Weakens: Against a backdrop of improving sentiment, bonds sold off, the dollar softened against major currencies, and commodities—including gold and oil—moved higher on Monday.
• Corporate Earnings Season Tops Expectations: With 91% of S&P 500 companies reporting, 81% have beaten analyst estimates, with an average surprise of 7.2%.
• Senate Narrowly Approves Federal Spending Bill: The Senate passed a federal spending bill late Monday by a 60–40 vote, just enough to overcome a Democratic filibuster. The measure now heads to the House for a potential vote today.
• Shutdown Seen Trimming Up to 2 Points from Q4 Growth: The Congressional Budget Office estimated that a six- to eight-week shutdown could shave 1.5 to 2 percentage points from fourth-quarter GDP growth.
• Gold Hits Three-Week High on Fed Rate-Cut Hopes: Gold prices climbed to a near three-week high Tuesday as expectations rose that an end to the government shutdown could pave the way for a Fed rate cut next month. Spot gold gained 0.3% to $4,126.77 per ounce at 3:13 p.m. ET.
• Tech Stocks Mixed as Nvidia, AMD Slip: Technology shares ended last week mixed: Oracle, AMD, and Super Micro fell 1–2%, while Nvidia pared losses and Palantir gained. Marvell Technology declined 2.5%.
• Tyson Foods Rises on Strong Earnings Despite Revenue Miss: Tyson Foods gained after posting better-than-expected earnings but lower revenue, maintaining steady guidance for fiscal 2026.
• Health Insurers Slide on Trump Subsidy Comments: Health insurance stocks dropped more than 2% after Trump suggested ACA subsidies be paid directly to consumers. UnitedHealth, HCA Healthcare, and Tenet Healthcare all fell.
• Diageo Names Former Tesco CEO to Revive Growth: Diageo shares jumped after appointing ex-Tesco CEO Dave Lewis as its new chief, following a recent downgrade to its 2026 sales outlook.
• Bitcoin, Crypto Stocks Rally on Renewed Risk Appetite: Bitcoin advanced as risk sentiment improved. Coinbase jumped 4% after reports of a retail token-launch platform, while MicroStrategy also gained.
• Airlines Climb on Optimism Shutdown Resolution Nears: Major airline stocks rose amid hopes the government shutdown will soon end, easing air-traffic controller shortages that caused hundreds of cancellations.
• Tesla Shares Dip After $1 Trillion Musk Pay Plan Approved
  Tesla shares fell after shareholders approved Elon Musk’s $1 trillion pay package, even as China sales hit a three-year low. The stock edged up 2% in early Monday trading.
• Nvidia Slips as SoftBank Exits Stake, CoreWeave Drops
  Nvidia fell after CoreWeave, in which it holds a stake, dropped 10% post-earnings and SoftBank confirmed selling its entire $5.9 billion position.
• CoreWeave Misses Guidance Despite Strong Q3 Revenue: CoreWeave beat quarterly revenue estimates but issued weaker full-year guidance, citing supply-chain issues tied to data-center delays. Analysts cut price targets after the report.
• Novo Nordisk Gains as Pfizer Wins Metsera Bidding War: Novo Nordisk rose after exiting the bidding for obesity-drug maker Metsera, which Pfizer acquired for up to $10 billion.
• Paramount Skydance Rallies on Stronger Guidance: Paramount Skydance jumped in premarket trading after issuing upbeat Q4 and FY2026 sales guidance despite missing revenue expectations.
• Rigetti Falls on Weak Revenue but Remains Up Sharply Y/Y: Rigetti Computing declined after posting weaker-than-expected revenue, though shares remain more than 2,000% higher year-over-year.
• Beyond Meat Drops on Wider-Than-Expected Quarterly Loss: Beyond Meat fell despite topping revenue estimates, as quarterly losses widened amid ongoing “category headwinds.”

_____________________________________________________________

“Ask not what your country can do for you – ask what you can do for your country.” – John F. Kennedy

_____________________________________________________________

Notable Stocks

• AMD (AMD) 
• Coreweave (CRWV)
• Tesla (TSLA)
• Nvidia (NVDA)
• Rigetti Cpmputing (RGTI)

Weekly Notables

Trump Signals Support for Senate Deal to End Historic Government Shutdown

President Donald Trump said Monday that he supports a pending bipartisan Senate deal aimed at ending the record-breaking 41-day U.S. government shutdown, signaling the clearest path yet to reopening federal agencies. “I would say so,” Trump told reporters in the Oval Office, “based on everything I’m hearing” about the agreement, which cleared a key procedural hurdle in the Senate on Sunday night. Any bill to restore government funding must ultimately be signed by the president to take effect. When asked whether he would also approve reversing his administration’s shutdown-related layoffs — a central provision of the proposed deal — Trump replied that he would “abide by the deal.”

Amgen CEO Highlights Breakthrough Results from Cholesterol Drug Trial

Amgen CEO Bob Bradway told CNBC’s Jim Cramer on Monday that new trial data show the company’s cholesterol-lowering drug Repatha can significantly reduce the risk of heart attacks. “This trial answered questions that have been on the mind of investigators, physicians, and patients for some time,” Bradway said on Mad Money. Amgen announced over the weekend that a phase III clinical trial found Repatha, when combined with standard cardiovascular therapies, lowered the risk of a first heart attack by 36%. The study also showed a 25% reduction in major cardiovascular events—such as heart attack or stroke—among high-risk patients who had not previously experienced either.

Earnings Spotlight: Walt Disney (DIS)

Disney is expected to release its quarterly earnings data on Thursday, November 13th before market open, per Finnhub. Analysts are expecting revenue of $22,976,327,430 and earnings of $1.06 per share.

What Else to Watch This Week

• Wednesday (Nov. 12): EIA Crude Oil Inventories, MBA Mortgage Applications Index. Earnings from Circle Internet Group Inc. (CRCL), Cisco Systems Inc. (CSCO), Flutter Entertainment PLC (FLUT), Globalfoundries Inc. (GFS), Manulife Financial Corp. (MFC), ON Holdings AG (ONON), Pan America Silver Corp. (PAAS), TransDigm Group Inc. (TDG), Tencent Music Entertainment Group (TME).
• Thursday (Nov. 13): Continuing Claims, Consumer Price Index (CPI), EIA Natural Gas Inventories, Initial Claims, Treasury Budget. Earnings from Applied Materials Inc. (AMAT), Bilibili Inc. (BILI), Brookfield Corp. (BN), Credicorp Ltd. (BAP), Dillard's Inc. (DDS), Ecopetrol SA (EC), JD.com (JD), NetEase Inc. (NTES), Walt Disney Co. (DIS).
• Friday (Nov. 14): Business Inventories, Producer Price Index (PPI), Retail Sales. Earnings from Alibaba Group Holding Ltd. (BABA), LATAM Airlines Group SA (LTM), Legence Corp. (LGN), RLX Technologies Inc. (RLX), Spire Inc. (SR).